ReviewJournal of cardiovascular imaging2026
Intraprocedural echocardiographic guidance in transcatheter aortic valve implantation.
Review in Journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcatheter aortic valve implantation (TAVI) is an established treatment for severe aortic stenosis across all surgical risk groups. Traditionally performed under general anesthesia with transesophageal echocardiography (TEE) guidance, TAVI has evolved toward a minimalist approach using local anesthesia and conscious sedation (LACS), supported by transthoracic echocardiography (TTE) or fluoroscopy alone. Despite this shift, intraprocedural imaging remains valuable as it offers real-time imaging guidance throughout the procedures, allowing for rapid and accurate assessment of complication and procedural results. Echocardiographic modalities used during TAVI include TTE, TEE (adult-, mini-, or micro-TEE) and intracardiac echocardiography (ICE), each with its own advantages and limitations. While TTE is widely used in uncomplicated cases, its image quality may be suboptimal, leading to missing complications and underestimation of paravalvular leak (PVL). In contrast, TEE provides superior spatial resolution, enabling comprehensive real-time assessment and improved PVL detection and other complications. Moreover, 3D TEE offers accurate assessment of the aortic annulus and aids in sizing of the prosthesis when computed tomography is suboptimal or unavailable. ICE is an attractive alternative as it provides real-time high-resolution images and can be performed under LACS by the same operator, although it is costly with single use and requires additional venous access. ICE may be particularly helpful in patients with challenging TTE windows, or in those with contraindications for TEE. We propose an upfront intraprocedural TEE strategy in patients with high-risk anatomies undergoing TAVI, and those with poor TTE window or renal impairment in whom minimal contrast usage is preferred. Mini-TEE (with a smaller probe) is the preferred modality for intraprocedural guidance, which has 3D imaging with good resolution, and is well tolerated under LACS. In conclusion, imaging strategies in TAVI should be individualized. While minimalist approaches are feasible, TEE remains indispensable in complex cases to optimize outcomes and minimize complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.